February 14, 2022

Amring Pharmaceuticals Inc. (Amring), a niche generic and brand pharmaceutical company, announced today that it has received FDA approval for generic Lamotrigine ODT, USP (25mg, 50mg, 100mg and 200mg) available in bottles of 30 tablets (AB rated generic equivalent of Lamictal®), and has begun commercialization activities.

Read more

844.304.4828 More contact options
Products Partner Company LinkedIn
More news & events